.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
Healthtrust
Merck
Fuji
Queensland Health
UBS
Mallinckrodt
Moodys
US Army
Daiichi Sankyo

Generated: February 24, 2018

DrugPatentWatch Database Preview

Patents Expiring in 2023

« Back to Dashboard

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
ShireINTUNIVguanfacine hydrochlorideTABLET, EXTENDED RELEASE;ORAL022037-004Sep 2, 2009ABRXYesYes➤ Try a Free Trial➤ Try a Free TrialY
ShireINTUNIVguanfacine hydrochlorideTABLET, EXTENDED RELEASE;ORAL022037-003Sep 2, 2009ABRXYesNo➤ Try a Free Trial➤ Try a Free TrialY
ShireINTUNIVguanfacine hydrochlorideTABLET, EXTENDED RELEASE;ORAL022037-002Sep 2, 2009ABRXYesNo➤ Try a Free Trial➤ Try a Free TrialY
ShireINTUNIVguanfacine hydrochlorideTABLET, EXTENDED RELEASE;ORAL022037-001Sep 2, 2009ABRXYesNo➤ Try a Free Trial➤ Try a Free TrialY
MedicisVANOSfluocinonideCREAM;TOPICAL021758-001Feb 11, 2005ABRXYesYes➤ Try a Free Trial➤ Try a Free TrialRELIEF OF THE INFLAMMATORY AND PRURITIC MANIFESTATIONS OF CORTICOSTEROID RESPONSIVE DERMATOSES IN PATIENTS 12 YEARS OF AGE OR OLDER
AllerganOZURDEXdexamethasoneIMPLANT;INTRAVITREAL022315-001Jun 17, 2009RXYesYes➤ Try a Free Trial➤ Try a Free TrialYTREATMENT OF MACULAR EDEMA
AllerganOZURDEXdexamethasoneIMPLANT;INTRAVITREAL022315-001Jun 17, 2009RXYesYes➤ Try a Free Trial➤ Try a Free TrialYTREATMENT OF UVEITIS
AllerganOZURDEXdexamethasoneIMPLANT;INTRAVITREAL022315-001Jun 17, 2009RXYesYes➤ Try a Free Trial➤ Try a Free TrialY
AllerganOZURDEXdexamethasoneIMPLANT;INTRAVITREAL022315-001Jun 17, 2009RXYesYes➤ Try a Free Trial➤ Try a Free TrialY
AllerganOZURDEXdexamethasoneIMPLANT;INTRAVITREAL022315-001Jun 17, 2009RXYesYes➤ Try a Free Trial➤ Try a Free TrialTREATMENT OF MACULAR EDEMA
This preview shows a limited number of results
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Medtronic
UBS
Daiichi Sankyo
Boehringer Ingelheim
Dow
Merck
AstraZeneca
Cerilliant
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2018 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot